Skip to content

Patient Reported Outcomes for Opioid Use Disorder

Capturing Opioid Use Disorder Electronically & Patient Reported Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03985163
Enrollment
101
Registered
2019-06-13
Start date
2019-06-07
Completion date
2020-02-16
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-use Disorder, Overdose of Opiate, Patient Participation

Keywords

Patient Reported Outcomes, Clinical Data Research, Electronic Health Records

Brief summary

The goal of the project is to build a clinical data research infrastructure that will begin to enhance capacity to use electronic health record (EHR) data and patient reported outcomes measures (PROs) to conduct opioid related research in emergency departments (EDs). 200 adult patients with a history of non-medical opioid use, opioid use disorder, or acute opioid overdose will be enrolled and will be asked to complete three PRO surveys (baseline, 3 days post ED discharge, and 30 days post discharge).

Interventions

OTHERPatient Reported Outcomes Electronic Survey

This study does not include a drug, test, behavioral or medical procedure intervention; participants will be asked to complete three surveys

Sponsors

National Drug Abuse Treatment Clinical Trials Network
CollaboratorNETWORK
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult patient presenting to the Yale New Haven Hospital York Street Campus emergency department * History of opioid use disorder or non-medical use of opioids, as measured by screening assessment OR receiving treatment for opioid overdose * Willingness and ability to complete electronic surveys via a smartphone or computer

Exclusion criteria

* \<18 years of age * Inability to communicate in English * Inability to provide consent (for example, due to psychosis, intoxication, severe mental illness or other reason) * Transfer from the ED for psychiatric evaluation

Design outcomes

Primary

MeasureTime frameDescription
Willingness to share EHR data with researchersonce: at screening and enrollmentThe proportion of people who qualify for study criteria and enroll in the study
Electronic survey responseonce: 3 day follow-up surveyResponse rate to patient reported outcomes via electronic follow-up survey

Secondary

MeasureTime frameDescription
ED patients referred to substance use disorder treatmentonce: 3 day follow-up surveyThe proportion of participants referred for substance use disorder treatment as part of routine emergency medical care
Patients enrolling in substance use disorder treatmentonce: 30 day follow-up surveyThe proportion of participants referred for substance use disorder treatment who enroll in substance use disorder treatment
Treatment Effectiveness Assessmentonce: 3 day follow-up surveyTreatment Effectiveness Assessment (TEA) elicits patient responses that help the patient and the clinician quickly gauge patient progress in treatment and in recovery, according to the patients' sense of what is important within four domains (substance use, health, lifestyle, and community) established by prior research
Lost-to-follow-upUp to 5 monthsLost-to-follow-up rates
Electronic survey responseonce: 30 day follow-up surveyResponse rate to patient reported outcomes via electronic follow-up survey
Patients filling opioid use disorder prescriptionsonce: 3 day follow-up surveyThe proportion of participants prescribed opioid use disorder medication who fill the opioid use disorder prescription
ED patients prescribed opioid use disorder medicationonce: 3 day follow-up surveyThe proportion of participants prescribed opioid use disorder medication as part of routine emergency medical care

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026